This inventor holds 1 USPTO granted patent. Top assignee: Yangzhou University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations of Hongxia Shao in the Fight Against COVID-19
Introduction
Hongxia Shao is a prominent inventor based in Jiangsu, China. She has made significant contributions to the field of biotechnology, particularly in the development of solutions for combating viral infections. Her work is especially relevant in the context of the ongoing global pandemic.
Latest Patents
Hongxia Shao holds a patent for a broad-spectrum peptide antigen of the novel coronavirus SARS-CoV-2. This invention includes a specific neutralizing antibody and its use, which is crucial for developing effective treatments and vaccines against COVID-19. Her innovative approach has the potential to enhance the efficacy of therapeutic interventions.
Career Highlights
Shao is affiliated with Yangzhou University, where she conducts her research and development activities. Her academic background and expertise in immunology have positioned her as a key figure in the fight against infectious diseases. With 1 patent to her name, she continues to push the boundaries of scientific research.
Collaborations
Throughout her career, Hongxia Shao has collaborated with notable colleagues, including Jianqiang Ye and Tuofan Li. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.
Conclusion
Hongxia Shao's contributions to the field of biotechnology, particularly in relation to COVID-19, highlight her role as an innovative inventor. Her work not only advances scientific knowledge but also has the potential to save lives through improved medical interventions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile